Development and validation of a UV/visible spectrophotometric method for simultaneous assay of paracetamol and ibuprofen
Introduction The quality of medicines and healthcare products is a significant challenge these days, with counterfeiting accounting for at least 10% of all products in circulation worldwide, including in Africa. In the specific case of the Democratic Republic of Congo (DR Congo), which is the se...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Orapuh, Inc.
2025-01-01
|
| Series: | Orapuh Journal |
| Subjects: | |
| Online Access: | https://www.orapuh.org/ojs/ojs-3.1.2-4/index.php/orapj/article/view/317 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850121920366772224 |
|---|---|
| author | Timothée Mavanga Mabaya Jocelyn Mankulu Kakumba Mannix Mayangi Makola Adelard Mbenza Puati Didi Mana Kialengila Jean Mavar Tayey Mbay Jérémie Mbinze Kindenge |
| author_facet | Timothée Mavanga Mabaya Jocelyn Mankulu Kakumba Mannix Mayangi Makola Adelard Mbenza Puati Didi Mana Kialengila Jean Mavar Tayey Mbay Jérémie Mbinze Kindenge |
| author_sort | Timothée Mavanga Mabaya |
| collection | DOAJ |
| description |
Introduction
The quality of medicines and healthcare products is a significant challenge these days, with counterfeiting accounting for at least 10% of all products in circulation worldwide, including in Africa. In the specific case of the Democratic Republic of Congo (DR Congo), which is the second-largest country on the continent and faces serious challenges in frontier control, the country has become a major hub for this scourge. Counterfeit medicines circulating within its territory account for over 20% of the pharmaceutical market.
Purpose
This research aimed to provide a simple, reliable, and economical method for quality control of drugs and healthcare products in the Congolese pharmaceutical market. This was achieved by developing and validating an ultraviolet-visible (UV-vis) spectrophotometric method for the simultaneous determination of paracetamol and ibuprofen in dosage forms.
Methods
From stock solutions, 0.65 ml of paracetamol and 0.8 ml of ibuprofen were transferred into volumetric flasks to prepare 10 ml of each solution. These solutions were separately scanned between 200-400 nm to observe the absorption maxima of each compound in UV-vis spectra against the blank (ethanol). Subsequently, individual solutions were prepared to obtain calibration and validation standards for the method validation, using the total error strategy and studying various validation criteria (specificity, precision, accuracy, linearity, robustness). After evaluating all the criteria, the developed and validated method was applied for the qualitative and quantitative analysis of dosage forms containing both paracetamol and ibuprofen.
Results
When solubilized in ethanol, paracetamol and ibuprofen exhibited absorption maxima at 249 nm and 219 nm, respectively. The method demonstrated strong correlation over the concentration ranges used (2.6–9.1 µg/ml for paracetamol and 3.2–9.6 µg/ml for ibuprofen). The correlation coefficients and regression lines determined at selected wavelengths were: y = 0.0924 x (R2 = 0.999) and y = 0.0228x (R2 = 0.9996) for paracetamol at 249 nm and 219 nm respectively, and y = 0.0429 x (R2 = 0.9993) for ibuprofen at 219 nm. The committed bias and the coefficient of variation in the precision study were within ±2% and less than 2%, respectively. Furthermore, the application of the method to dosage forms produced appropriate active ingredient rates, which ranged between 98% and 102%.
Conclusion
The developed method showed no interference between the active ingredients and the usual excipients used in tablet manufacturing. The recovery rates obtained in the selectivity and accuracy studies were consistently between 98% and 102%. Active ingredient contents determined by applying the method to pharmaceutical dosage forms ranged between 95% and 105%.
|
| format | Article |
| id | doaj-art-cf817854fa0a46718cd6e6e32008769f |
| institution | OA Journals |
| issn | 2644-3740 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Orapuh, Inc. |
| record_format | Article |
| series | Orapuh Journal |
| spelling | doaj-art-cf817854fa0a46718cd6e6e32008769f2025-08-20T02:34:56ZengOrapuh, Inc.Orapuh Journal2644-37402025-01-016110.4314/orapj.v6i1.2Development and validation of a UV/visible spectrophotometric method for simultaneous assay of paracetamol and ibuprofenTimothée Mavanga Mabaya0Jocelyn Mankulu Kakumba1Mannix Mayangi Makola2Adelard Mbenza Puati3Didi Mana Kialengila4Jean Mavar Tayey Mbay5Jérémie Mbinze Kindenge6University of Kinshasa, Kinshasa XI, Democratic Republic of the CongoUniversity of Kinshasa, Kinshasa XI, Democratic Republic of the CongoUniversity of Kinshasa, Kinshasa XI, Democratic Republic of the CongoUniversity of Kinshasa, Kinshasa XI, Democratic Republic of the CongoUniversity of Kinshasa, Kinshasa XI, Democratic Republic of the CongoUniversity of Kinshasa, Kinshasa XI, Democratic Republic of the CongoUniversity of Kinshasa, Kinshasa XI, Democratic Republic of the Congo Introduction The quality of medicines and healthcare products is a significant challenge these days, with counterfeiting accounting for at least 10% of all products in circulation worldwide, including in Africa. In the specific case of the Democratic Republic of Congo (DR Congo), which is the second-largest country on the continent and faces serious challenges in frontier control, the country has become a major hub for this scourge. Counterfeit medicines circulating within its territory account for over 20% of the pharmaceutical market. Purpose This research aimed to provide a simple, reliable, and economical method for quality control of drugs and healthcare products in the Congolese pharmaceutical market. This was achieved by developing and validating an ultraviolet-visible (UV-vis) spectrophotometric method for the simultaneous determination of paracetamol and ibuprofen in dosage forms. Methods From stock solutions, 0.65 ml of paracetamol and 0.8 ml of ibuprofen were transferred into volumetric flasks to prepare 10 ml of each solution. These solutions were separately scanned between 200-400 nm to observe the absorption maxima of each compound in UV-vis spectra against the blank (ethanol). Subsequently, individual solutions were prepared to obtain calibration and validation standards for the method validation, using the total error strategy and studying various validation criteria (specificity, precision, accuracy, linearity, robustness). After evaluating all the criteria, the developed and validated method was applied for the qualitative and quantitative analysis of dosage forms containing both paracetamol and ibuprofen. Results When solubilized in ethanol, paracetamol and ibuprofen exhibited absorption maxima at 249 nm and 219 nm, respectively. The method demonstrated strong correlation over the concentration ranges used (2.6–9.1 µg/ml for paracetamol and 3.2–9.6 µg/ml for ibuprofen). The correlation coefficients and regression lines determined at selected wavelengths were: y = 0.0924 x (R2 = 0.999) and y = 0.0228x (R2 = 0.9996) for paracetamol at 249 nm and 219 nm respectively, and y = 0.0429 x (R2 = 0.9993) for ibuprofen at 219 nm. The committed bias and the coefficient of variation in the precision study were within ±2% and less than 2%, respectively. Furthermore, the application of the method to dosage forms produced appropriate active ingredient rates, which ranged between 98% and 102%. Conclusion The developed method showed no interference between the active ingredients and the usual excipients used in tablet manufacturing. The recovery rates obtained in the selectivity and accuracy studies were consistently between 98% and 102%. Active ingredient contents determined by applying the method to pharmaceutical dosage forms ranged between 95% and 105%. https://www.orapuh.org/ojs/ojs-3.1.2-4/index.php/orapj/article/view/317simultaneousValidationUV-vis spectrophotometryParacetamolIbuprofen |
| spellingShingle | Timothée Mavanga Mabaya Jocelyn Mankulu Kakumba Mannix Mayangi Makola Adelard Mbenza Puati Didi Mana Kialengila Jean Mavar Tayey Mbay Jérémie Mbinze Kindenge Development and validation of a UV/visible spectrophotometric method for simultaneous assay of paracetamol and ibuprofen Orapuh Journal simultaneous Validation UV-vis spectrophotometry Paracetamol Ibuprofen |
| title | Development and validation of a UV/visible spectrophotometric method for simultaneous assay of paracetamol and ibuprofen |
| title_full | Development and validation of a UV/visible spectrophotometric method for simultaneous assay of paracetamol and ibuprofen |
| title_fullStr | Development and validation of a UV/visible spectrophotometric method for simultaneous assay of paracetamol and ibuprofen |
| title_full_unstemmed | Development and validation of a UV/visible spectrophotometric method for simultaneous assay of paracetamol and ibuprofen |
| title_short | Development and validation of a UV/visible spectrophotometric method for simultaneous assay of paracetamol and ibuprofen |
| title_sort | development and validation of a uv visible spectrophotometric method for simultaneous assay of paracetamol and ibuprofen |
| topic | simultaneous Validation UV-vis spectrophotometry Paracetamol Ibuprofen |
| url | https://www.orapuh.org/ojs/ojs-3.1.2-4/index.php/orapj/article/view/317 |
| work_keys_str_mv | AT timotheemavangamabaya developmentandvalidationofauvvisiblespectrophotometricmethodforsimultaneousassayofparacetamolandibuprofen AT jocelynmankulukakumba developmentandvalidationofauvvisiblespectrophotometricmethodforsimultaneousassayofparacetamolandibuprofen AT mannixmayangimakola developmentandvalidationofauvvisiblespectrophotometricmethodforsimultaneousassayofparacetamolandibuprofen AT adelardmbenzapuati developmentandvalidationofauvvisiblespectrophotometricmethodforsimultaneousassayofparacetamolandibuprofen AT didimanakialengila developmentandvalidationofauvvisiblespectrophotometricmethodforsimultaneousassayofparacetamolandibuprofen AT jeanmavartayeymbay developmentandvalidationofauvvisiblespectrophotometricmethodforsimultaneousassayofparacetamolandibuprofen AT jeremiembinzekindenge developmentandvalidationofauvvisiblespectrophotometricmethodforsimultaneousassayofparacetamolandibuprofen |